الولايات المتحدة · أخبار عامة · NBC News

Personalized mRNA vaccine for melanoma cut risk of cancer’s return in late-stage trial

نشره NBC News · الولايات المتحدة منذ 1 س

Moderna and Merck’s personalized mRNA vaccine for melanoma reduced the risk of cancer recurrence and death by 42% compared with standard treatment in a trial.

اقرأ المقال كاملًا على NBC News سجّل الدخول للحفظ

يعرض MarketNews العنوان والملخص كما نشرتهما الوسيلة الإعلامية. المقال الكامل متوفر على موقع الناشر. (www.nbcnews.com)

يستحق القراءة أيضًا

Mongabay

Bangladesh’s climate migrants are arriving in cities unprepared to protect them

The Hill

DeSantis gifts Trump gold coin with engraved image of him ‘flipping the bird’

Fox News

CHAOS INC.: Who's who in the global mayhem network? Communists, Antifa, agitators in the red-green alliance.

ABC News

Vance could be a major Category 3 hurricane Friday as it nears Mexico

New York Post

Registered sex offender, 29, busted trying to enroll in high school as teen girl — and it’s not his first time

PBS NewsHour